IMBRIA Trademark

Trademark Overview

On Wednesday, November 14, 2018, a trademark application was filed for IMBRIA with the United States Patent and Trademark Office. The USPTO has given the IMBRIA trademark a serial number of 88985327. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Friday, June 28, 2024. This trademark is owned by Imbria Pharmaceuticals, Inc.. The IMBRIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for treatment of cardiovascular diseases
imbria

General Information

Serial Number88985327
Word MarkIMBRIA
Filing DateWednesday, November 14, 2018
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateFriday, June 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2023

Trademark Statements

Goods and ServicesPharmaceuticals for treatment of cardiovascular diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, December 1, 2018
Primary Code005
First Use Anywhere DateThursday, December 31, 2020
First Use In Commerce DateThursday, December 31, 2020

Trademark Owner History

Party NameImbria Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02110
Party NameImbria Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Trademark Events

Event DateEvent Description
Wednesday, February 20, 2019LETTER OF SUSPENSION E-MAILED
Saturday, November 17, 2018NEW APPLICATION ENTERED
Saturday, December 1, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 19, 2019ASSIGNED TO EXAMINER
Wednesday, February 20, 2019SUSPENSION LETTER WRITTEN
Wednesday, February 20, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, June 7, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, June 13, 2019ASSIGNED TO LIE
Friday, June 14, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 14, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 24, 2019SUSPENSION LETTER WRITTEN
Monday, June 24, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, June 24, 2019LETTER OF SUSPENSION E-MAILED
Thursday, January 30, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, August 5, 2020ASSIGNED TO LIE
Thursday, August 6, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, March 24, 2021SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, April 12, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, October 22, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, May 27, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, January 18, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, January 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 28, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 25, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, October 25, 2023TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, October 25, 2023SOU EXTENSION 1 FILED
Wednesday, October 25, 2023DIVISIONAL REQUEST RECEIVED
Wednesday, October 25, 2023USE AMENDMENT FILED
Wednesday, October 25, 2023TEAS STATEMENT OF USE RECEIVED
Monday, October 30, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 20, 2023ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Tuesday, November 21, 2023RESPONSE TO ITU OFFICE ACTION ENTERED
Tuesday, November 21, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 30, 2023SOU EXTENSION 1 GRANTED
Thursday, November 30, 2023DIVISIONAL PROCESSING COMPLETE
Thursday, November 30, 2023STATEMENT OF USE PROCESSING COMPLETE
Friday, December 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 10, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 8, 2024SU - NON-FINAL ACTION - WRITTEN
Monday, January 8, 2024NON-FINAL ACTION E-MAILED
Monday, January 8, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 4, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, April 4, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, June 20, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 20, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 20, 2024ASSIGNED TO LIE
Friday, June 28, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, June 28, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

imbria diseases cardiovascular treatment pharmaceuticals